[1]
|
Sharp, P.M. and Hahn, B.H. (2011) Origins of HIV and the AIDS Pandemic. Cold Spring Harbor Perspectives in Medicine, 1, a006841. https://doi.org/10.1101/cshperspect.a006841
|
[2]
|
Badley, A.D., Pilon, A.A., Landay, A. and Lynch, D.H. (2000) Mechanisms of HIV-Associated Lymphocyte Apoptosis. Blood, 96, 2951-2964. https://doi.org/10.1182/blood.V96.9.2951
|
[3]
|
中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版) [J]. 协和医学杂志, 2022, 13(2): 203-226.
|
[4]
|
甘秀敏, 赵德才, 赵燕, 马烨, 吴亚松, 豆智慧. 2003-2021年我国艾滋病抗病毒治疗工作进展情况分析[J]. 中国艾滋病性病, 2022, 28(6): 642-646.
|
[5]
|
Arts, E.J. and Hazuda, D.J. (2012) HIV-1 Antiretroviral Drug Therapy. Cold Spring Harbor Perspectives in Medicine, 2, a007161. https://doi.org/10.1101/cshperspect.a007161
|
[6]
|
Cao, W., Hsieh, E. and Li, T. (2020) Optimizing Treatment for Adults with HIV/AIDS in China: Successes over Two Decades and Remaining Challenges. Current HIV/AIDS Reports, 17, 26-34.
https://doi.org/10.1007/s11904-019-00478-x
|
[7]
|
Simon, V., Ho, D.D. and Abdool, K.Q. (2006) HIV/AIDS Epi-demiology, Pathogenesis, Prevention, and Treatment. The Lancet, 368, 489-504. https://doi.org/10.1016/S0140-6736(06)69157-5
|
[8]
|
Lundgren, J.D., et al. (2015) Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. The New England Journal of Medicine, 373, 795-807. https://doi.org/10.1056/NEJMoa1506816
|
[9]
|
李永勤, 杨学刚, 粱叶, 刘洋, 赵静, 路新利. 2005-2020年保定市艾滋病患者抗艾滋病病毒治疗免疫学效果影响因素分析[J]. 中国皮肤性病学杂志, 2023, 37(2): 196-201.
|
[10]
|
McComsey, G.A., Lingohr-Smith, M., Rogers, R., Lin, J. and Donga, P. (2021) Real-World Adherence to Antiretroviral Therapy among HIV-1 Patients across the United States. Advances in Therapy, 38, 4961-4974.
https://doi.org/10.1007/s12325-021-01883-8
|
[11]
|
Leyva-Moral, J.M., et al. (2019) Adherence to Antiretroviral Therapy and the Associated Factors among People Living with HIV/AIDS in Northern Peru: A Cross-Sectional Study. AIDS Research and Therapy, 16, Article No. 22.
https://doi.org/10.1186/s12981-019-0238-y
|
[12]
|
Liu, P., et al. (2018) Adherence, Virological Outcome, and Drug Resistance in Chinese HIV Patients Receiving First- Line Antiretroviral Therapy from 2011 to 2015. Medicine, 97, e13555. https://doi.org/10.1097/MD.0000000000013555
|
[13]
|
Kang, R., et al. (2019) Treatment Outcomes of Initial Differential Antiretroviral Regimens among HIV Patients in Southwest China: Comparison from an Observational Cohort Study. BMJ Open, 9, e025666.
https://doi.org/10.1136/bmjopen-2018-025666
|
[14]
|
Neupane, S., Dhungana, G.P. and Ghimire, H.C. (2019) Ad-herence to Antiretroviral Treatment and Associated Factors among People Living with HIV and AIDS in CHITWAN, Nepal. BMC Public Health, 19, Article No. 720.
https://doi.org/10.1186/s12889-019-7051-3
|
[15]
|
Ceylan, E., Koç, A., Inkaya, A.Ç. and Ünal, S. (2019) Determi-nation of Medication Adherence and Related Factors among People Living with HIV/AIDS in a Turkish University Hospital. Turkish Journal of Medical Sciences, 49,198-205.
https://doi.org/10.3906/sag-1802-137
|
[16]
|
Molla, A.A., Gelagay, A.A., Mekonnen, H.S. and Teshome, D.F. (2018) Adherence to Antiretroviral Therapy and Associated Factors among HIV Positive Adults Attending Care and Treatment in University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infectious Diseases, 18, Article No. 266. https://doi.org/10.1186/s12879-018-3176-8
|
[17]
|
Meshesha, H.M., Nigussie, Z.M., Asrat, A. and Mulatu, K. (2022) Determinants of Virological Failure among Adults on First-Line Highly Active Antiretroviral Therapy at Public Health Facilities in Kombolcha Town, Northeast, Ethiopia: A Case-Control Study. BMJ Open, 10, e036223. https://doi.org/10.1136/bmjopen-2019-036223
|
[18]
|
Zenu, S., Tesema, T., Reshad, M. and Abebe, E. (2021) De-terminants of First-Line Antiretroviral Treatment Failure among Adult Patients on Treatment in Mettu Karl Specialized Hospital, South West Ethiopia; a Case Control Study. PLOS ONE, 16, e0258930. https://doi.org/10.1371/journal.pone.0258930
|
[19]
|
Abadiga, M., Hasen, T., Mosisa, G. and Abdisa, E. (2020) Adherence to Antiretroviral Therapy and Associated Factors among Human Immunodeficiency Virus Positive Patients Accessing Treatment at Nekemte Referral Hospital, West Ethiopia, 2019. PLOS ONE, 15, e0232703. https://doi.org/10.1371/journal.pone.0232703
|
[20]
|
Blassel, L., et al. (2021) Drug Resistance Mutations in HIV: New Bioinformatics Approaches and Challenges. Current Opinion in Virology, 51, 56-64. ttps://doi.org/10.1016/j.coviro.2021.09.009
|
[21]
|
Shchemelev, A.N., Ostankova, Y.V., Zueva, E.B., Semenov, A.V. and Totolian, A.A. (2022) Detection of Patient HIV-1 Drug Resistance Mutations in Russia’s Northwestern Federal District in Patients with Treatment Failure. Diagnostics, 12, Article 1821. https://doi.org/10.3390/diagnostics12081821
|
[22]
|
Khairunisa, S.Q., et al. (2020) Identification of HIV-1 Subtypes and Drug Resistance Mutations among HIV-1-Infected Individuals Residing in Pontianak, Indonesia. Germs, 10, 174-183. https://doi.org/10.18683/germs.2020.1203
|
[23]
|
戴色莺, 刘爱文, 沈月兰, 程晓莉, 张进, 吴建军, 吴家兵, 邢辉, 阮玉华. 安徽省接受抗病毒治疗HIV/AIDS死亡的影响因素[J]. 中华疾病控制杂志, 2022, 26(12): 1379-1383, 1401.
|
[24]
|
Hauser, A., et al. (2022) Acquired HIV Drug Resistance Mutations on First-Line Antiretroviral Therapy in Southern Africa: Systematic Review and Bayesian Evidence Synthesis. Journal of Clinical Epidemiology, 148, 135-145.
https://doi.org/10.1016/j.jclinepi.2022.02.005
|
[25]
|
Armenia, D., et al. (2022) Bictegravir/Emtricitabine/Tenofovir Alafenamide Ensures High Rates of Virological Suppression Maintenance Despite Previous Resistance in PLWH Who Optimize Treatment in Clinical Practice. Journal of Global Antimicrobial Resistance, 30, 326-334. https://doi.org/10.1016/j.jgar.2022.06.027
|
[26]
|
Salvo, P.F., et al. (2023) Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens according to Resistance Mutations and Viral Subtype. Viruses, 15, Article 762. https://doi.org/10.3390/v15030762
|
[27]
|
Mahomed, K., et al. (2020) Case Report: Emergence of Dolutegravir Resistance in a Patient on Second-Line Antiretroviral Therapy. Southern African Journal of HIV Medicine, 21, a1062.
https://doi.org/10.4102/sajhivmed.v21i1.1062
|
[28]
|
Mandikiyana, C.L., Pascoe, M.J. and Lowe, S. (2022) Emergent Dolutegravir Resistance in Integrase-Naïve, Treatment Experienced Patients from Zimbabwe. Southern African Journal of HIV Medicine, 23, a1435.
https://doi.org/10.4102/sajhivmed.v23i1.1435
|
[29]
|
Leveille, S.G. and Thapa, S. (2017) Disability among Persons Aging with HIV/AIDS. Interdisciplinary Topics in Gerontology and Geriatrics, 42, 101-118. https://doi.org/10.1159/000448547
|
[30]
|
Yang, X., et al. (2020) Incomplete Immune Reconstitution in HIV/AIDS Patients on Antiretroviral Therapy: Challenges of Immunological Non-Responders. Journal of Leukocyte Biology, 107, 597-612.
https://doi.org/10.1002/JLB.4MR1019-189R
|
[31]
|
Handoko, R., et al. (2020) Determinants of Suboptimal CD4+ T Cell Recovery after Antiretroviral Therapy Initiation in a Prospective Cohort of Acute HIV-1 Infection. Journal of the International AIDS Society, 23, e25585.
https://doi.org/10.1002/jia2.25585
|
[32]
|
Darraj, M., Shafer, L.A., Chan, S., Kasper, K. and Keynan, Y. (2018) Rapid CD4 Decline Prior to Antiretroviral Therapy Predicts Subsequent Failure to Reconstitute Despite HIV Viral Sup-pression. Journal of Infection and Public Health, 11, 265-269. https://doi.org/10.1016/j.jiph.2017.08.001
|
[33]
|
Shete, A., et al. (2019) Incomplete Functional T-Cell Reconstitution in Immunological Non-Responders at One Year after Initiation of Antiretroviral Therapy Possibly Predisposes Them to Infectious Diseases. International Journal of Infectious Diseases, 81, 114-122. https://doi.org/10.1016/j.ijid.2019.01.017
|
[34]
|
Li, T., et al. (2011) Reduced Thymic Output Is a Major Mechanism of Immune Reconstitution Failure in HIV-Infected Patients after Long-Term Antiretroviral Therapy. Clinical Infectious Diseases, 53, 944-951.
https://doi.org/10.1093/cid/cir552
|
[35]
|
Sudharshan, S. and Biswas, J. (2008) Introduction and Immunopathogenesis of Acquired Immune Deficiency Syndrome. Indian Journal of Ophthalmology, 56, 357-362. https://doi.org/10.4103/0301-4738.42411
|
[36]
|
Limper, A.H., Adenis, A., Le, T. and Harrison, P.T.S. (2017) Fungal Infections in HIV/AIDS. The Lancet Infectious Diseases, 17, E334-E343. https://doi.org/10.1016/S1473-3099(17)30303-1
|
[37]
|
Huang, L. and Crothers, K. (2009) HIV-Associated Oppor-tunistic Pneumonias. Respirology, 14, 474-485.
https://doi.org/10.1111/j.1440-1843.2009.01534.x
|
[38]
|
Woldegeorgis, B.Z., Diro, C.W., Yohannes, B., Kerbo, A.A. and Asgedom, Y.S. (2022) Incidence and Predictors of Opportunistic Infections in Adolescents and Adults after the Initiation of Antiretroviral Therapy: A 10-Year Retrospective Cohort Study in Ethiopia. Frontiers in Public Health, 10, Article 1064859.
https://doi.org/10.3389/fpubh.2022.1064859
|